SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-013203
Filing Date
2024-04-04
Accepted
2024-04-04 16:54:50
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm   iXBRL 20-F 2864198
2 ex2-1.htm EX-2.1 88686
3 ex8-1.htm EX-8.1 8112
4 ex12-1.htm EX-12.1 11767
5 ex12-2.htm EX-12.2 11785
6 ex13-1.htm EX-13.1 10387
7 ex15-1.htm EX-15.1 5970
8 ex97-1.htm EX-97.1 82132
9 form20-f_001.jpg GRAPHIC 93790
10 form20-f_002.jpg GRAPHIC 61983
11 form20-f_003.jpg GRAPHIC 62431
12 form20-f_004.jpg GRAPHIC 56350
13 form20-f_005.jpg GRAPHIC 67640
  Complete submission text file 0001493152-24-013203.txt   9503815

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE glmd-20231231.xsd EX-101.SCH 44140
15 XBRL CALCULATION FILE glmd-20231231_cal.xml EX-101.CAL 62252
16 XBRL DEFINITION FILE glmd-20231231_def.xml EX-101.DEF 199928
17 XBRL LABEL FILE glmd-20231231_lab.xml EX-101.LAB 352073
18 XBRL PRESENTATION FILE glmd-20231231_pre.xml EX-101.PRE 287238
90 EXTRACTED XBRL INSTANCE DOCUMENT form20-f_htm.xml XML 1184204
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36345 | Film No.: 24823758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)